SIGN UPLog In

General

Financials

People

Activity

Recent News
SR One
SR One

Company

Investment-firm

Financing round

General

About Company
SR One Capital Management is a biotech venture capital firm.

Related to

GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline is a global healthcare company focused on improving people's health and well-being.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

London, UK

total rounds

2

total raised

$25.51M

count Of Investments

25

count Of Exists

3

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1985

Number of employees

1-10

IPO status

Private

Description

SR One Capital Management, a division of GlaxoSmithKline, is a transatlantic biotech venture capital firm that partners with top entrepreneurs, scientists, and investment partners to build elite biotechnology companies. With offices in San Francisco and London, SR One provides funding, knowledge, and networking support to high-potential healthcare companies in the United States and Europe at all stages of development. Operating on an evergreen basis since 1985, SR One focuses on translating innovative technologies into potential next-generation medicines that address significant unmet medical needs.
Contacts

location

Cambridge, MA, USA

Phone number

Website URL

http://www.srone.com

Social url

Similar Companies
1000
F2 Ventures
F2 VenturesF2 Ventures is a venture capital and private equity firm focused on investing in the biotechnology sector.
F2 Ventures

F2 Ventures

F2 Ventures is a venture capital and private equity firm focused on investing in the biotechnology sector.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

London, UK

count Of Investments

19

count Of Exists

3
Sofinnova Investments
Sofinnova InvestmentsSofinnova Investments is a venture capital firm that specializes in funding and supporting Life Science and Technology start-ups.
Sofinnova Investments

Sofinnova Investments

Sofinnova Investments is a venture capital firm that specializes in funding and supporting Life Science and Technology start-ups.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Menlo Park, CA, USA

count Of Investments

236

count Of Exists

58
Longitude Capital
Longitude CapitalLongitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.
Longitude Capital

Longitude Capital

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Menlo Park, CA, USA

count Of Investments

113

count Of Exists

16
Burrill & Company
Burrill & CompanyBurrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.
Burrill & Company

Burrill & Company

Burrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Biotechnology

Location

San Francisco, CA, USA

count Of Investments

70

count Of Exists

21

Financials

Investments
158
Date 
name 
Lead 
type 
Raised 
17.07.2024
Renalys Pharma
Renalys Pharma
Yes
Series A
$42.17M
Local Amount - JPY 6B
16.07.2024
Asceneuron
Asceneuron
No
Series C
$100M
27.06.2024
Kala Pharmaceuticals
Kala Pharmaceuticals
Yes
Post-IPO Equity
$12.5M
Renalys Pharma

Renalys Pharma

Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.

Location

Tokyo, Japan

total rounds

1

total raised

$42.17M
Asceneuron

Asceneuron

Asceneuron is a biotech company that develops effective therapeutics for orphan tauopathies and Alzheimer's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Lausanne, Switzerland

total rounds

4

total raised

$129.18M
Kala Pharmaceuticals

Kala Pharmaceuticals

Kala Pharmaceuticals develops treatments for mucosal diseases using proprietary technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Waltham, MA, USA

total rounds

13

total raised

$549.87M
Co-Investors
Exits
36
River Vision Development
River Vision DevelopmentRiver Vision Development develops RV001, a protein therapy for treating Graves' Orbitopathy (GO).
River Vision Development

River Vision Development

River Vision Development develops RV001, a protein therapy for treating Graves' Orbitopathy (GO).

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

4

total raised

$33.3M
ZappRx
ZappRxZappRx is a digital health company that simplifies the management of specialty medications.
ZappRx

ZappRx

ZappRx is a digital health company that simplifies the management of specialty medications.

Sector

Personal Care, Drug and Grocery Stores

Subsector

Drug Retailers

Keywords

Health Care, Pharmaceuticals, Medical

Location

Boston, MA, USA

total rounds

4

total raised

$41M
Alios BioPharma
Alios BioPharmaAlios BioPharma develops innovative treatments for viral diseases.
Alios BioPharma

Alios BioPharma

Alios BioPharma develops innovative treatments for viral diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Biopharma, Pharmaceuticals

Location

South San Francisco, CA, USA

total rounds

4

total raised

$74.4M

People

Employee Profiles
26
Christopher Y. Chai
Christopher Y. Chai

Christopher Y. Chai

Venture Partner

Venture Partner

Deborah Harland
Deborah Harland

Deborah Harland

Venture Partner

Venture Partner

Amit Shah

Amit Shah

Biotech venture capital senior associate

Biotech venture capital senior associate

Shaun Foy
Shaun Foy

Shaun Foy

Venture Partner

Venture Partner

Jens Eckstein
Jens Eckstein

Jens Eckstein

President

President

Jill Carroll
Jill Carroll

Jill Carroll

Partner

Partner

Matthew Foy
Matthew Foy

Matthew Foy

Partner

Partner

Christine Timmons

Christine Timmons

Administrative assistant

Administrative assistant

Activity

Recent News
14
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week